17 Einträge gefunden

1. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

   1. Sibal, Latika
   2. Agarwal, Sharad C
   3. Schwedhelm, Edzard
   4. Lüneburg, Nicole
   5. Böger, Rainer
   6. Home, Philip D

   2009 - Forschungsinformationssystem des UKE - frei zugänglich
2. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.

   1. Ostad, Mir Abolfazl
   2. Eggeling, Silke
   3. Tschentscher, Peter
   4. Schwedhelm, Edzard
   5. Böger, Rainer
   6. Wenzel, Philip
   7. Meinertz, Thomas

   2009 - Forschungsinformationssystem des UKE
3. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

   1. Pikula, Aleksandra
   2. Böger, Rainer
   3. Beiser, Alexa S
   4. Maas, Renke
   5. DeCarli, Charles
   6. Schwedhelm, Edzard
   7. Himali, Jayandra J

   2009 - Forschungsinformationssystem des UKE
4. HNO exacerbates ischemic cerebral injury and oxidative neurotoxicity.

   1. Choe, Chi-Un
   2. Lewerenz, Jan
   3. Fischer, Gerry
   4. Uliasz, Tracy F
   5. Espey, Michael Graham
   6. Hummel, Friedhelm
   7. Bruce King, S

   2009 - Forschungsinformationssystem des UKE
5. Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

   1. Lieb, Wolfgang
   2. Benndorf, Ralf
   3. Benjamin, Emelia J
   4. Sullivan Lisa, M
   5. Maas, Renke
   6. Xanthakis, Vanessa
   7. Schwedhelm, Edzard

   2009 - Forschungsinformationssystem des UKE
6. Renal resistance index in renal allograft recipients: a role for ADMA.

   1. Bergmann, Ivo P
   2. Böger, Rainer
   3. Marti, Elizabeth
   4. Frey, Felix J
   5. Schwedhelm, Edzard
   6. Eisenberger, Ute

   2009 - Forschungsinformationssystem des UKE
7. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.

   1. Böger, Rainer
   2. Maas, Renke
   3. Schulze, Friedrich
   4. Schwedhelm, Edzard

   2009 - Forschungsinformationssystem des UKE
8. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.

   1. Maas, Renke
   2. Xanthakis, Vanessa
   3. Polak, Joseph F
   4. Schwedhelm, Edzard
   5. Sullivan Lisa, M
   6. Benndorf, Ralf
   7. Schulze, Friedrich

   2009 - Forschungsinformationssystem des UKE
9. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.

   1. Broedbaek, Kasper
   2. Poulsen, Henrik E
   3. Weimann, Allan
   4. Kom, Ghainsom D
   5. Schwedhelm, Edzard
   6. Nielsen, Peter
   7. Böger, Rainer

   2009 - Forschungsinformationssystem des UKE
10. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

    1. Böger, Rainer
    2. Sullivan Lisa, M
    3. Schwedhelm, Edzard
    4. Wang, Thomas J
    5. Maas, Renke
    6. Benjamin, Emelia J
    7. Schulze, Friedrich

    2009 - Forschungsinformationssystem des UKE
11. Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.

    1. Schulze, Friedrich
    2. Vollert, Jörn
    3. Maas, Renke
    4. Müller, Reinhold
    5. Schwedhelm, Edzard
    6. Müller, Christian
    7. Böger, Rainer

    2009 - Forschungsinformationssystem des UKE
12. Quantification of arginine and its mono- and dimethylated analogs NMMA, ADMA and SDMA in biological fluids by LC-MS/MS: Is LC superfluous?

    1. Martens-Lobenhoffer, Jens
    2. Schwedhelm, Edzard
    3. Tsikas, Dimitrios

    2009 - Forschungsinformationssystem des UKE
13. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.

    1. Hu, Xinli
    2. Xu, Xin
    3. Zhu, Guangshuo
    4. Atzler, Dorothee
    5. Kimoto, Masumi
    6. Chen, Ju
    7. Schwedhelm, Edzard

    2009 - Forschungsinformationssystem des UKE
14. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.

    1. Benndorf, Ralf
    2. Krebs, Christian
    3. Hirsch-Hoffmann, Birgit
    4. Schwedhelm, Edzard
    5. Cieslar, Gabriele
    6. Schmidt-Haupt, Robin
    7. Steinmetz, Oliver

    2009 - Forschungsinformationssystem des UKE
15. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.

    1. Schwedhelm, Edzard
    2. Xanthakis, Vanessa
    3. Maas, Renke
    4. Sullivan Lisa, M
    5. Schulze, Friedrich
    6. Riederer, Ulrich
    7. Benndorf, Ralf

    2009 - Forschungsinformationssystem des UKE
16. Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.

    1. Leypoldt, Frank
    2. Choe, Chi-Un
    3. Gelderblom, Mathias
    4. von Leitner, Eike-Christin
    5. Atzler, Dorothee
    6. Schwedhelm, Edzard
    7. Gerloff, Christian

    2009 - Forschungsinformationssystem des UKE - frei zugänglich
17. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.

    1. Schulze, Friedrich
    2. Glos, Sabrina
    3. Petruschka, Dörte
    4. Altenburg, Christiane
    5. Maas, Renke
    6. Benndorf, Ralf
    7. Schwedhelm, Edzard

    2009 - Forschungsinformationssystem des UKE